Ranked #1

Outcome of third salvage autologous stem cell transplantation in multiple myeloma
Outcome of third salvage autologous stem cell transplantation in multiple myeloma
Dr Garderet speaks with ecancer at the 16th International Myeloma Workshop about the outcome of third salvage autologous... Read more
1 Aug 2017
•
6mins
Ranked #2

Is precision myeloma medicine more hype than reality?
Is precision myeloma medicine more hype than reality?
Dr Lentzsch speaks with ecancer at the 16th International Myeloma Workshop about genomics and disease monitoring and deb... Read more
1 Aug 2017
•
4mins
Ranked #3

IMW 2017 highlights
IMW 2017 highlights
Dr Garderet speaks with ecancer at the 16th International Myeloma Workshop about the highlights of IMW 2017, particularl... Read more
1 Aug 2017
•
2mins
Ranked #4

Caring for multiple myeloma carers
Caring for multiple myeloma carers
Monica Morris speaks with ecancer at the 16th International Myeloma Workshop about findings from a study into the experi... Read more
1 Aug 2017
•
3mins
Ranked #5

Long term effects of myeloma treatment
Long term effects of myeloma treatment
Monica Morris speaks with ecancer at the 16th International Myeloma Workshop about guidelines for screening and manageme... Read more
1 Aug 2017
•
2mins
Ranked #6

Update on CASTOR trial: Daratumumab, bortezomib, and dexamethasone for relapsed or refractory myeloma
Update on CASTOR trial: Daratumumab, bortezomib, and dexamethasone for relapsed or refractory myeloma
Dr Lentzsch speaks with ecancer at the 16th International Myeloma Workshop about the CASTOR trial.The CASTOR trial is a ... Read more
1 Aug 2017
•
2mins
Ranked #7

Asia-Pacific approaches to myeloma trials
Asia-Pacific approaches to myeloma trials
Prof Chng speaks with ecancer at the 16th International Myeloma Workshop about the landscape of current international tr... Read more
1 Aug 2017
•
5mins
Ranked #8

What is the biology behind immunotherapy for MM?
What is the biology behind immunotherapy for MM?
Dr Lesokhin speaks with ecancer at the 16th International Myeloma Workshop about the biology behind immunotherapy in MM ... Read more
1 Aug 2017
•
7mins
Ranked #9

Impact of recurrent myeloma alterations on drug response
Impact of recurrent myeloma alterations on drug response
Dr Majumder speaks with ecancer at the 16th International Myeloma Workshop about increased mutational burden and alterat... Read more
1 Aug 2017
•
5mins
Ranked #10

Evaluating efficacy of denosumab compared with zoledronic acid in symptomatic myeloma
Evaluating efficacy of denosumab compared with zoledronic acid in symptomatic myeloma
Dr Raje speaks with ecancer at the 16th International Myeloma Workshop about an international, randomised, double blind ... Read more
1 Aug 2017
•
4mins